Literature DB >> 16457992

Pathological pattern of Mdx mice diaphragm correlates with gradual expression of the short utrophin isoform Up71.

Karim Hnia1, Sylvie Tuffery-Giraud, Marianne Vermaelen, Gerald Hugon, Delphine Chazalette, Ahmed Masmoudi, François Rivier, Dominique Mornet.   

Abstract

Utrophin gene is transcribed in a large mRNA of 13 kb that codes for a protein of 395 kDa. It shows amino acid identity with dystrophin of up to 73% and is widely expressed in muscle and non-muscle tissues. Up71 is a short utrophin product of the utrophin gene with the same cysteine-rich and C-terminal domains as full-length utrophin (Up395). Using RT-PCR, Western blots analysis, we demonstrated that Up71 is overexpressed in the mdx diaphragm, the most pathological muscle in dystrophin-deficient mdx mice, compared to wild-type C57BL/10 or other mdx skeletal muscles. Subsequently, we demonstrated that this isoform displayed an increased expression level up to 12 months, whereas full-length utrophin (Up395) decreased. In addition, beta-dystroglycan, the transmembrane glycoprotein that anchors the cytoplasmic C-terminal domain of utrophin, showed similar increase expression in mdx diaphragm, as opposed to other components of the dystrophin-associated protein complex (DAPC) such as alpha-dystrobrevin1 and alpha-sarcoglycan. We demonstrated that Up71 and beta-dystroglycan were progressively accumulated along the extrasynaptic region of regenerating clusters in mdx diaphragm. Our data provide novel functional insights into the pathological role of the Up71 isoform in dystrophinopathies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457992      PMCID: PMC1974843          DOI: 10.1016/j.bbadis.2005.11.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

1.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

2.  alpha7B integrin changes in mdx mouse muscles after L-arginine administration.

Authors:  Delphine Chazalette; Karim Hnia; François Rivier; Gérald Hugon; Dominique Mornet
Journal:  FEBS Lett       Date:  2005-02-14       Impact factor: 4.124

Review 3.  Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies.

Authors:  Joe V Chakkalakal; Jennifer Thompson; Robin J Parks; Bernard J Jasmin
Journal:  FASEB J       Date:  2005-06       Impact factor: 5.191

4.  Dystrophin and utrophin complexed with different associated proteins in cardiac Purkinje fibres.

Authors:  F Rivier; A Robert; G Hugon; A Bonet-Kerrache; V Nigro; J A Fehrentz; J Martinez; D Mornet
Journal:  Histochem J       Date:  1999-07

5.  The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.

Authors:  Joji Takahashi; Yuka Itoh; Keita Fujimori; Michihiro Imamura; Yoshihiro Wakayama; Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  J Gene Med       Date:  2005-02       Impact factor: 4.565

Review 6.  Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.

Authors:  A O Gramolini; J Wu; B J Jasmin
Journal:  Microsc Res Tech       Date:  2000-04-01       Impact factor: 2.769

7.  Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise.

Authors:  Akinori Nakamura; Kunihiro Yoshida; Hideho Ueda; Shin'ichi Takeda; Shu-ichi Ikeda
Journal:  Biochim Biophys Acta       Date:  2004-12-30

8.  Myosin molecular motor dysfunction in dystrophic mouse diaphragm.

Authors:  C Coirault; F Lambert; S Marchand-Adam; P Attal; D Chemla; Y Lecarpentier
Journal:  Am J Physiol       Date:  1999-12

9.  Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity.

Authors:  Mario Bermúdez de León; Cecilia Montañez; Pablo Gómez; Sara Luz Morales-Lázaro; Victor Tapia-Ramírez; Viviana Valadez-Graham; Félix Recillas-Targa; David Yaffe; Uri Nudel; Bulmaro Cisneros
Journal:  J Biol Chem       Date:  2004-11-18       Impact factor: 5.157

10.  Force transmission, compliance, and viscoelasticity are altered in the alpha7-integrin-null mouse diaphragm.

Authors:  M A Lopez; U Mayer; W Hwang; T Taylor; M A Hashmi; S R Jannapureddy; Aladin M Boriek
Journal:  Am J Physiol Cell Physiol       Date:  2005-02       Impact factor: 4.249

View more
  4 in total

Review 1.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

2.  Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice.

Authors:  Emeka K Enwere; Louise Boudreault; Janelle Holbrook; Kristen Timusk; Nathalie Earl; Eric LaCasse; Jean-Marc Renaud; Robert G Korneluk
Journal:  Hum Mol Genet       Date:  2012-11-25       Impact factor: 6.150

3.  Second-generation compound for the modulation of utrophin in the therapy of DMD.

Authors:  Simon Guiraud; Sarah E Squire; Benjamin Edwards; Huijia Chen; David T Burns; Nandini Shah; Arran Babbs; Stephen G Davies; Graham M Wynne; Angela J Russell; David Elsey; Francis X Wilson; Jon M Tinsley; Kay E Davies
Journal:  Hum Mol Genet       Date:  2015-05-01       Impact factor: 6.150

4.  Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy.

Authors:  Oshrat Levi; Olga Genin; Corrado Angelini; Orna Halevy; Mark Pines
Journal:  Oncotarget       Date:  2015-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.